Gao Peng, Chang Xin, Zhang Dagan, Cai Yafei, Chen Gen, Wang Hao, Wang Tianfu
Guangdong Key Laboratory of Biomedical Measurements and Ultrasound Imaging, Department of Biomedical Engineering, Shenzhen University, Shenzhen 518060, China.
State Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering, Southeast University, Nanjing 210096, China.
Acta Pharm Sin B. 2021 May;11(5):1175-1199. doi: 10.1016/j.apsb.2020.12.004. Epub 2020 Dec 15.
Therapeutic nanoparticles are designed to enhance efficacy, real-time monitoring, targeting accuracy, biocompatibility, biodegradability, safety, and the synergy of diagnosis and treatment of diseases by leveraging the unique physicochemical and biological properties of well-developed bio-nanomaterials. Recently, bio-inspired metal nanoclusters (NCs) consisting of several to roughly dozens of atoms (<2 nm) have attracted increasing research interest, owing to their ultrafine size, tunable fluorescent capability, good biocompatibility, variable metallic composition, and extensive surface bio-functionalization. Hybrid core-shell nanostructures that effectively incorporate unique fluorescent inorganic moieties with various biomolecules, such as proteins (enzymes, antigens, and antibodies), DNA, and specific cells, create fluorescently visualized molecular nanoparticle. The resultant nanoparticles possess combinatorial properties and synergistic efficacy, such as simplicity, active bio-responsiveness, improved applicability, and low cost, for combination therapy, such as accurate targeting, bioimaging, and enhanced therapeutic and biocatalytic effects. In contrast to larger nanoparticles, bio-inspired metal NCs allow rapid renal clearance and better pharmacokinetics in biological systems. Notably, advances in nanoscience, interfacial chemistry, and biotechnologies have further spurred researchers to explore bio-inspired metal NCs for therapeutic purposes. The current review presents a comprehensive and timely overview of various metal NCs for various therapeutic applications, with a special emphasis on the design rationale behind the use of biomolecules/cells as the main scaffolds. In the different hybrid platform, we summarize the current challenges and emerging perspectives, which are expected to offer in-depth insight into the rational design of bio-inspired metal NCs for personalized treatment and clinical translation.
治疗性纳米颗粒旨在通过利用成熟的生物纳米材料独特的物理化学和生物学特性,提高疾病治疗的疗效、实现实时监测、提高靶向准确性、增强生物相容性、生物可降解性、安全性以及诊断与治疗的协同性。最近,由几个到大约几十个原子组成(<2nm)的仿生金属纳米团簇(NCs)因其超小尺寸、可调荧光能力、良好的生物相容性、可变的金属组成以及广泛的表面生物功能化而吸引了越来越多的研究兴趣。将独特的荧光无机部分与各种生物分子(如蛋白质(酶、抗原和抗体)、DNA和特定细胞)有效结合的杂化核壳纳米结构,创造出了可荧光可视化的分子纳米颗粒。所得的纳米颗粒具有组合特性和协同功效,如简单性、主动生物响应性、更高的适用性和低成本,可用于联合治疗,如精确靶向、生物成像以及增强治疗和生物催化效果。与较大的纳米颗粒相比,仿生金属纳米团簇在生物系统中具有快速肾清除率和更好的药代动力学。值得注意的是,纳米科学、界面化学和生物技术的进展进一步促使研究人员探索用于治疗目的的仿生金属纳米团簇。本综述全面且及时地概述了各种用于不同治疗应用的金属纳米团簇,特别强调了以生物分子/细胞作为主要支架的设计原理。在不同的杂化平台中,我们总结了当前的挑战和新出现的观点,期望能为个性化治疗和临床转化的仿生金属纳米团簇的合理设计提供深入见解。